Refine your search
Collections
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Merlin, N. J.
- Peroxisome Proliferator-Activated Receptors (PPARs) -A Review
Abstract Views :229 |
PDF Views:2
Authors
Affiliations
1 Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Thiruvananthapuram, Kerala, IN
1 Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Thiruvananthapuram, Kerala, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 4, No 1 (2014), Pagination: 32-37Abstract
PPARs are ligand-activated transcription factors involved in the transcriptional regulation of key metabolic pathways such as lipid metabolism, adipogenesis, and insulin sensitivity. More recent work implicates all 3 PPAR isotypes (α, γ, and δ) in inflammatory and atherosclerotic pathways. Because these nuclear receptors are activated by extracellular signals and control multiple gene targets, PPARs can be seen as nodes that control multiple inputs and outputs involved in energy balance, providing insight into how metabolism and the vasculature may be integrated. The ongoing clinical use of synthetic PPAR agonists, eg, insulin-sensitizing thiazolidinediones (TZDs) and lipid-lowering fibrates, and the evidence that PPAR activation also may limit inflammation and atherosclerosis have only heightened this interest and the pursuit of novel PPAR agonists. Together, these various observations have stimulated intense interest in PPARs as therapeutic targets and led to large-scale cardiovascular end-point trials with PPAR agonists.References
- Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res. 2003 Dec;44(12):2234-41.
- Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr. 2004 Jun;79(6):1118-25.
- Lefebvre AM, Chen I, Desreumaux P, Najib J, Fruchart JC, Geboes K, Briggs M, Heyman R, Auwerx J 1998 Activation of the peroxisome proliferator-activated receptor g promotes the development of colon tumors in C57BL/6J-APCMin/1 mice. Nat Med 4:1053-1057
- Saez E, Tontonoz P, Nelson MC, Alvarez JGA, Ming UT, Baird S, Thomazy VA, EvansRM1998 Activators of the nuclear receptor PPARg enhance colon polyp formation. Nat Med 4: 1058-1061
- Ito Y, Azrolan N, O’Connell A, Walsh A, Breslow JL 1990 Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249:790-793
- Lock EA, Mitchell AM, Elcombe CR 1989 Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29:145-163
- Gulick T, Cresci S, Caira T, Moore DD, Kelly DP 1994 The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91:11012-11016
- Nano Technology –Potential Applications in Medicine
Abstract Views :201 |
PDF Views:0
Authors
Affiliations
1 Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Thiruvananthapuram, Kerala, IN
1 Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Thiruvananthapuram, Kerala, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 1, No 2 (2011), Pagination: 31-35Abstract
Nanotechnology is the science that deals with the processes that occur at molecular level. Nanotechnology is a multidisciplinary field, convergence of basic sciences and applied disciplines like biophysics, molecular biology, and bioengineering. It has created powerful impact in various fields of medicine including cardiology, ophthalmology, endocrinology, oncology, pulmonology, immunology etc., and to highly specialized areas like gene delivery, brain targeting, tumor targeting, and oral vaccine formulations. Nanotechnology provides intelligent systems, devices and materials for better pharmaceutical applications.- River Blindness – An Eye Disorder
Abstract Views :184 |
PDF Views:0
Authors
N. J. Merlin
1,
Arya
2
Affiliations
1 Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Thiruvananthapuram, Kerala, HU
2 Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Thiruvananthapuram, Kerala, IN
1 Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Thiruvananthapuram, Kerala, HU
2 Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyattinkara, Thiruvananthapuram, Kerala, IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 1, No 2 (2011), Pagination: 39-41Abstract
Onchocerciasis, also known as river blindness and Robles' Disease, is a parasitic disease caused by infection by Onchocerca volvulus. Doxycycline and Ivermycetin are used to treat this disease.- Pharmacy Careers - An Overview
Abstract Views :194 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmacology, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyatinkara, IN
1 Department of Pharmacology, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom, Neyyatinkara, IN